101ST GENERAL ASSEMBLY
State of Illinois
2019 and 2020
SB2972

 

Introduced 2/4/2020, by Sen. Jennifer Bertino-Tarrant

 

SYNOPSIS AS INTRODUCED:
 
See Index

    Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Provides that the Director of Public Health, if a physician licensed to practice medicine in all its branches in Illinois, shall establish a standing order complete with the issuance of a prescription for a hormonal contraceptive in accordance with the requirements of the provisions. Provides that if the Director is not a physician licensed to practice medicine in all its branches in Illinois, the Medical Director of the Department of Public Health shall establish the standing order. Amends the Illinois Insurance Code. Requires a group or individual policy of accident and health insurance or managed care plan to provide coverage for patient care services provided by a pharmacist. Makes conforming changes in the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, and the School Code. Amends the Pharmacy Practice Act. Provides that the definition of "practice of pharmacy" includes the dispensing of hormonal contraceptives pursuant to the standing order under provisions of the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Amends the Illinois Public Aid Code. Requires the medical assistance program to cover patient care services provided by a pharmacist for hormonal contraceptives assessment and consultation. Effective January 1, 2021.


LRB101 19948 SPS 69555 b

FISCAL NOTE ACT MAY APPLY
STATE MANDATES ACT MAY REQUIRE REIMBURSEMENT

 

 

A BILL FOR

 

SB2972LRB101 19948 SPS 69555 b

1    AN ACT concerning regulation.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The State Employees Group Insurance Act of 1971
5is amended by changing Section 6.11 as follows:
 
6    (5 ILCS 375/6.11)
7    (Text of Section before amendment by P.A. 101-625)
8    Sec. 6.11. Required health benefits; Illinois Insurance
9Code requirements. The program of health benefits shall provide
10the post-mastectomy care benefits required to be covered by a
11policy of accident and health insurance under Section 356t of
12the Illinois Insurance Code. The program of health benefits
13shall provide the coverage required under Sections 356g,
14356g.5, 356g.5-1, 356m, 356u, 356w, 356x, 356z.2, 356z.4,
15356z.4a, 356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12,
16356z.13, 356z.14, 356z.15, 356z.17, 356z.22, 356z.25, 356z.26,
17356z.29, 356z.30a, 356z.32, and 356z.33, and 356z.43 of the
18Illinois Insurance Code. The program of health benefits must
19comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and
20370c.1, and Article XXXIIB of the Illinois Insurance Code. The
21Department of Insurance shall enforce the requirements of this
22Section with respect to Sections 370c and 370c.1 of the
23Illinois Insurance Code; all other requirements of this Section

 

 

SB2972- 2 -LRB101 19948 SPS 69555 b

1shall be enforced by the Department of Central Management
2Services.
3    Rulemaking authority to implement Public Act 95-1045, if
4any, is conditioned on the rules being adopted in accordance
5with all provisions of the Illinois Administrative Procedure
6Act and all rules and procedures of the Joint Committee on
7Administrative Rules; any purported rule not so adopted, for
8whatever reason, is unauthorized.
9(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
10100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
111-1-19; 100-1102, eff. 1-1-19; 100-1170, eff. 6-1-19; 101-13,
12eff. 6-12-19; 101-281, eff. 1-1-20; 101-393, eff. 1-1-20;
13101-452, eff. 1-1-20; 101-461, eff. 1-1-20; revised 10-16-19.)
 
14    (Text of Section after amendment by P.A. 101-625)
15    Sec. 6.11. Required health benefits; Illinois Insurance
16Code requirements. The program of health benefits shall provide
17the post-mastectomy care benefits required to be covered by a
18policy of accident and health insurance under Section 356t of
19the Illinois Insurance Code. The program of health benefits
20shall provide the coverage required under Sections 356g,
21356g.5, 356g.5-1, 356m, 356u, 356w, 356x, 356z.2, 356z.4,
22356z.4a, 356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12,
23356z.13, 356z.14, 356z.15, 356z.17, 356z.22, 356z.25, 356z.26,
24356z.29, 356z.30a, 356z.32, 356z.33, 356z.36, and 356z.41, and
25356z.43 of the Illinois Insurance Code. The program of health

 

 

SB2972- 3 -LRB101 19948 SPS 69555 b

1benefits must comply with Sections 155.22a, 155.37, 355b,
2356z.19, 370c, and 370c.1 and Article XXXIIB of the Illinois
3Insurance Code. The Department of Insurance shall enforce the
4requirements of this Section with respect to Sections 370c and
5370c.1 of the Illinois Insurance Code; all other requirements
6of this Section shall be enforced by the Department of Central
7Management Services.
8    Rulemaking authority to implement Public Act 95-1045, if
9any, is conditioned on the rules being adopted in accordance
10with all provisions of the Illinois Administrative Procedure
11Act and all rules and procedures of the Joint Committee on
12Administrative Rules; any purported rule not so adopted, for
13whatever reason, is unauthorized.
14(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
15100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
161-1-19; 100-1102, eff. 1-1-19; 100-1170, eff. 6-1-19; 101-13,
17eff. 6-12-19; 101-281, eff. 1-1-20; 101-393, eff. 1-1-20;
18101-452, eff. 1-1-20; 101-461, eff. 1-1-20; 101-625, eff.
191-1-21.)
 
20    Section 10. The Department of Public Health Powers and
21Duties Law of the Civil Administrative Code of Illinois is
22amended by adding Section 2310-705 as follows:
 
23    (20 ILCS 2310/2310-705 new)
24    Sec. 2310-705. Contraceptive drugs and products; Director

 

 

SB2972- 4 -LRB101 19948 SPS 69555 b

1standing order.
2    (a) As used in this Section:
3    "Hormonal contraceptive" means a prescribed
4medically-acceptable oral drug, transdermal patch, or vaginal
5ring that is approved by the United States Food and Drug
6Administration to prevent pregnancy.
7    "Standing order" has the meaning given to that term in the
8Pharmacy Practice Act.
9    (b) If the Director of Public Health is a physician
10licensed to practice medicine in all its branches in Illinois,
11the Director shall establish a standing order complete with the
12issuance of a prescription for a hormonal contraceptive in
13accordance with this Section. If the Director is not a
14physician licensed to practice medicine in all its branches in
15Illinois, then the Medical Director of the Department of Public
16Health shall establish a standing order in accordance with this
17Section.
18    (c) The standing order, at a minimum, shall comply with the
19following:
20        (1) A pharmacist may dispense a 12-month supply of
21    hormonal contraceptives to a patient.
22        (2) A pharmacist shall have the patient complete the
23    self-screening risk assessment tool. The self-screening
24    risk assessment tool is to be based on the most current
25    version of the United States Medical Eligibility Criteria
26    for Contraceptive Use published by the federal Centers for

 

 

SB2972- 5 -LRB101 19948 SPS 69555 b

1    Disease Control and Prevention.
2        (3) Based upon the results of the self-screening risk
3    assessment and the patient assessment, the pharmacist
4    shall use his or her professional and clinical judgment as
5    to when a patient should be referred to the patient's
6    physician or another health care provider.
7        (4) The pharmacist shall provide, during the patient
8    assessment and consultation, counseling and education
9    about all methods of contraception, including methods not
10    covered under the standing order, and their proper use and
11    effectiveness.
12        (5) The patient consultation shall take place in a
13    private manner consistent with rules adopted by the
14    Department of Financial and Professional Regulation.
15        (6) The Department shall adopt rules under this Section
16    that require a pharmacist to:
17            (A) complete an educational training program
18        accredited by the Accreditation Council for Pharmacy
19        Education and approved by the Department that is
20        related to the patient self-screening risk assessment,
21        patient assessment, contraceptive counseling and
22        education, and dispensation of hormonal
23        contraceptives; and
24            (B) dispense the hormonal contraceptive to the
25        patient as soon as practicable after meeting the
26        requirements of paragraph (2).

 

 

SB2972- 6 -LRB101 19948 SPS 69555 b

1        (7) All State and federal laws governing insurance
2    coverage of contraceptive drugs shall apply to hormonal
3    contraceptives dispensed by a pharmacist under this
4    Section.
 
5    Section 15. The Counties Code is amended by changing
6Section 5-1069.3 as follows:
 
7    (55 ILCS 5/5-1069.3)
8    (Text of Section before amendment by P.A. 101-625)
9    Sec. 5-1069.3. Required health benefits. If a county,
10including a home rule county, is a self-insurer for purposes of
11providing health insurance coverage for its employees, the
12coverage shall include coverage for the post-mastectomy care
13benefits required to be covered by a policy of accident and
14health insurance under Section 356t and the coverage required
15under Sections 356g, 356g.5, 356g.5-1, 356u, 356w, 356x,
16356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12, 356z.13,
17356z.14, 356z.15, 356z.22, 356z.25, 356z.26, 356z.29,
18356z.30a, and 356z.32, and 356z.33, and 356z.43 of the Illinois
19Insurance Code. The coverage shall comply with Sections
20155.22a, 355b, 356z.19, and 370c of the Illinois Insurance
21Code. The Department of Insurance shall enforce the
22requirements of this Section. The requirement that health
23benefits be covered as provided in this Section is an exclusive
24power and function of the State and is a denial and limitation

 

 

SB2972- 7 -LRB101 19948 SPS 69555 b

1under Article VII, Section 6, subsection (h) of the Illinois
2Constitution. A home rule county to which this Section applies
3must comply with every provision of this Section.
4    Rulemaking authority to implement Public Act 95-1045, if
5any, is conditioned on the rules being adopted in accordance
6with all provisions of the Illinois Administrative Procedure
7Act and all rules and procedures of the Joint Committee on
8Administrative Rules; any purported rule not so adopted, for
9whatever reason, is unauthorized.
10(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
11100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
121-1-19; 100-1102, eff. 1-1-19; 101-81, eff. 7-12-19; 101-281,
13eff. 1-1-20; 101-393, eff. 1-1-20; 101-461, eff. 1-1-20;
14revised 10-16-19.)
 
15    (Text of Section after amendment by P.A. 101-625)
16    Sec. 5-1069.3. Required health benefits. If a county,
17including a home rule county, is a self-insurer for purposes of
18providing health insurance coverage for its employees, the
19coverage shall include coverage for the post-mastectomy care
20benefits required to be covered by a policy of accident and
21health insurance under Section 356t and the coverage required
22under Sections 356g, 356g.5, 356g.5-1, 356u, 356w, 356x,
23356z.6, 356z.8, 356z.9, 356z.10, 356z.11, 356z.12, 356z.13,
24356z.14, 356z.15, 356z.22, 356z.25, 356z.26, 356z.29,
25356z.30a, 356z.32, 356z.33, 356z.36, and 356z.41, and 356z.43

 

 

SB2972- 8 -LRB101 19948 SPS 69555 b

1of the Illinois Insurance Code. The coverage shall comply with
2Sections 155.22a, 355b, 356z.19, and 370c of the Illinois
3Insurance Code. The Department of Insurance shall enforce the
4requirements of this Section. The requirement that health
5benefits be covered as provided in this Section is an exclusive
6power and function of the State and is a denial and limitation
7under Article VII, Section 6, subsection (h) of the Illinois
8Constitution. A home rule county to which this Section applies
9must comply with every provision of this Section.
10    Rulemaking authority to implement Public Act 95-1045, if
11any, is conditioned on the rules being adopted in accordance
12with all provisions of the Illinois Administrative Procedure
13Act and all rules and procedures of the Joint Committee on
14Administrative Rules; any purported rule not so adopted, for
15whatever reason, is unauthorized.
16(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
17100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
181-1-19; 100-1102, eff. 1-1-19; 101-81, eff. 7-12-19; 101-281,
19eff. 1-1-20; 101-393, eff. 1-1-20; 101-461, eff. 1-1-20;
20101-625, eff. 1-1-21.)
 
21    Section 20. The Illinois Municipal Code is amended by
22changing Section 10-4-2.3 as follows:
 
23    (65 ILCS 5/10-4-2.3)
24    (Text of Section before amendment by P.A. 101-625)

 

 

SB2972- 9 -LRB101 19948 SPS 69555 b

1    Sec. 10-4-2.3. Required health benefits. If a
2municipality, including a home rule municipality, is a
3self-insurer for purposes of providing health insurance
4coverage for its employees, the coverage shall include coverage
5for the post-mastectomy care benefits required to be covered by
6a policy of accident and health insurance under Section 356t
7and the coverage required under Sections 356g, 356g.5,
8356g.5-1, 356u, 356w, 356x, 356z.6, 356z.8, 356z.9, 356z.10,
9356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 356z.22, 356z.25,
10356z.26, 356z.29, 356z.30a, and 356z.32, and 356z.33, and
11356z.43 of the Illinois Insurance Code. The coverage shall
12comply with Sections 155.22a, 355b, 356z.19, and 370c of the
13Illinois Insurance Code. The Department of Insurance shall
14enforce the requirements of this Section. The requirement that
15health benefits be covered as provided in this is an exclusive
16power and function of the State and is a denial and limitation
17under Article VII, Section 6, subsection (h) of the Illinois
18Constitution. A home rule municipality to which this Section
19applies must comply with every provision of this Section.
20    Rulemaking authority to implement Public Act 95-1045, if
21any, is conditioned on the rules being adopted in accordance
22with all provisions of the Illinois Administrative Procedure
23Act and all rules and procedures of the Joint Committee on
24Administrative Rules; any purported rule not so adopted, for
25whatever reason, is unauthorized.
26(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;

 

 

SB2972- 10 -LRB101 19948 SPS 69555 b

1100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
21-1-19; 100-1102, eff. 1-1-19; 101-81, eff. 7-12-19; 101-281,
3eff. 1-1-20; 101-393, eff. 1-1-20; 101-461, eff. 1-1-20;
4revised 10-16-19.)
 
5    (Text of Section after amendment by P.A. 101-625)
6    Sec. 10-4-2.3. Required health benefits. If a
7municipality, including a home rule municipality, is a
8self-insurer for purposes of providing health insurance
9coverage for its employees, the coverage shall include coverage
10for the post-mastectomy care benefits required to be covered by
11a policy of accident and health insurance under Section 356t
12and the coverage required under Sections 356g, 356g.5,
13356g.5-1, 356u, 356w, 356x, 356z.6, 356z.8, 356z.9, 356z.10,
14356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 356z.22, 356z.25,
15356z.26, 356z.29, 356z.30a, 356z.32, 356z.33, 356z.36, and
16356z.41, and 356z.43 of the Illinois Insurance Code. The
17coverage shall comply with Sections 155.22a, 355b, 356z.19, and
18370c of the Illinois Insurance Code. The Department of
19Insurance shall enforce the requirements of this Section. The
20requirement that health benefits be covered as provided in this
21is an exclusive power and function of the State and is a denial
22and limitation under Article VII, Section 6, subsection (h) of
23the Illinois Constitution. A home rule municipality to which
24this Section applies must comply with every provision of this
25Section.

 

 

SB2972- 11 -LRB101 19948 SPS 69555 b

1    Rulemaking authority to implement Public Act 95-1045, if
2any, is conditioned on the rules being adopted in accordance
3with all provisions of the Illinois Administrative Procedure
4Act and all rules and procedures of the Joint Committee on
5Administrative Rules; any purported rule not so adopted, for
6whatever reason, is unauthorized.
7(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
8100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
91-1-19; 100-1102, eff. 1-1-19; 101-81, eff. 7-12-19; 101-281,
10eff. 1-1-20; 101-393, eff. 1-1-20; 101-461, eff. 1-1-20;
11101-625, eff. 1-1-21.)
 
12    Section 25. The School Code is amended by changing Section
1310-22.3f as follows:
 
14    (105 ILCS 5/10-22.3f)
15    (Text of Section before amendment by P.A. 101-625)
16    Sec. 10-22.3f. Required health benefits. Insurance
17protection and benefits for employees shall provide the
18post-mastectomy care benefits required to be covered by a
19policy of accident and health insurance under Section 356t and
20the coverage required under Sections 356g, 356g.5, 356g.5-1,
21356u, 356w, 356x, 356z.6, 356z.8, 356z.9, 356z.11, 356z.12,
22356z.13, 356z.14, 356z.15, 356z.22, 356z.25, 356z.26, 356z.29,
23356z.30a, and 356z.32, and 356z.33, and 356z.43 of the Illinois
24Insurance Code. Insurance policies shall comply with Section

 

 

SB2972- 12 -LRB101 19948 SPS 69555 b

1356z.19 of the Illinois Insurance Code. The coverage shall
2comply with Sections 155.22a, 355b, and 370c of the Illinois
3Insurance Code. The Department of Insurance shall enforce the
4requirements of this Section.
5    Rulemaking authority to implement Public Act 95-1045, if
6any, is conditioned on the rules being adopted in accordance
7with all provisions of the Illinois Administrative Procedure
8Act and all rules and procedures of the Joint Committee on
9Administrative Rules; any purported rule not so adopted, for
10whatever reason, is unauthorized.
11(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
12100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
131-1-19; 100-1102, eff. 1-1-19; 101-81, eff. 7-12-19; 101-281,
14eff. 1-1-20; 101-393, eff. 1-1-20; 101-461, eff. 1-1-20;
15revised 10-16-19.)
 
16    (Text of Section after amendment by P.A. 101-625)
17    Sec. 10-22.3f. Required health benefits. Insurance
18protection and benefits for employees shall provide the
19post-mastectomy care benefits required to be covered by a
20policy of accident and health insurance under Section 356t and
21the coverage required under Sections 356g, 356g.5, 356g.5-1,
22356u, 356w, 356x, 356z.6, 356z.8, 356z.9, 356z.11, 356z.12,
23356z.13, 356z.14, 356z.15, 356z.22, 356z.25, 356z.26, 356z.29,
24356z.30a, 356z.32, 356z.33, 356z.36, and 356z.41, and 356z.43
25of the Illinois Insurance Code. Insurance policies shall comply

 

 

SB2972- 13 -LRB101 19948 SPS 69555 b

1with Section 356z.19 of the Illinois Insurance Code. The
2coverage shall comply with Sections 155.22a, 355b, and 370c of
3the Illinois Insurance Code. The Department of Insurance shall
4enforce the requirements of this Section.
5    Rulemaking authority to implement Public Act 95-1045, if
6any, is conditioned on the rules being adopted in accordance
7with all provisions of the Illinois Administrative Procedure
8Act and all rules and procedures of the Joint Committee on
9Administrative Rules; any purported rule not so adopted, for
10whatever reason, is unauthorized.
11(Source: P.A. 100-24, eff. 7-18-17; 100-138, eff. 8-18-17;
12100-863, eff. 8-14-18; 100-1024, eff. 1-1-19; 100-1057, eff.
131-1-19; 100-1102, eff. 1-1-19; 101-81, eff. 7-12-19; 101-281,
14eff. 1-1-20; 101-393, eff. 1-1-20; 101-461, eff. 1-1-20;
15101-625, eff. 1-1-21.)
 
16    Section 30. The Illinois Insurance Code is amended by
17adding Section 356z.43 as follows:
 
18    (215 ILCS 5/356z.43 new)
19    Sec. 356z.43. Coverage for patient care services for
20hormonal contraceptives provided by a pharmacist. A group or
21individual policy of accident and health insurance or a managed
22care plan that is amended, delivered, issued, or renewed after
23the effective date of this amendatory Act of the 101st General
24Assembly shall provide coverage for patient care services

 

 

SB2972- 14 -LRB101 19948 SPS 69555 b

1provided by a pharmacist for hormonal contraceptives
2assessment and consultation.
 
3    Section 35. The Pharmacy Practice Act is amended by
4changing Section 3 as follows:
 
5    (225 ILCS 85/3)
6    (Section scheduled to be repealed on January 1, 2023)
7    Sec. 3. Definitions. For the purpose of this Act, except
8where otherwise limited therein:
9    (a) "Pharmacy" or "drugstore" means and includes every
10store, shop, pharmacy department, or other place where
11pharmacist care is provided by a pharmacist (1) where drugs,
12medicines, or poisons are dispensed, sold or offered for sale
13at retail, or displayed for sale at retail; or (2) where
14prescriptions of physicians, dentists, advanced practice
15registered nurses, physician assistants, veterinarians,
16podiatric physicians, or optometrists, within the limits of
17their licenses, are compounded, filled, or dispensed; or (3)
18which has upon it or displayed within it, or affixed to or used
19in connection with it, a sign bearing the word or words
20"Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care",
21"Apothecary", "Drugstore", "Medicine Store", "Prescriptions",
22"Drugs", "Dispensary", "Medicines", or any word or words of
23similar or like import, either in the English language or any
24other language; or (4) where the characteristic prescription

 

 

SB2972- 15 -LRB101 19948 SPS 69555 b

1sign (Rx) or similar design is exhibited; or (5) any store, or
2shop, or other place with respect to which any of the above
3words, objects, signs or designs are used in any advertisement.
4    (b) "Drugs" means and includes (1) articles recognized in
5the official United States Pharmacopoeia/National Formulary
6(USP/NF), or any supplement thereto and being intended for and
7having for their main use the diagnosis, cure, mitigation,
8treatment or prevention of disease in man or other animals, as
9approved by the United States Food and Drug Administration, but
10does not include devices or their components, parts, or
11accessories; and (2) all other articles intended for and having
12for their main use the diagnosis, cure, mitigation, treatment
13or prevention of disease in man or other animals, as approved
14by the United States Food and Drug Administration, but does not
15include devices or their components, parts, or accessories; and
16(3) articles (other than food) having for their main use and
17intended to affect the structure or any function of the body of
18man or other animals; and (4) articles having for their main
19use and intended for use as a component or any articles
20specified in clause (1), (2) or (3); but does not include
21devices or their components, parts or accessories.
22    (c) "Medicines" means and includes all drugs intended for
23human or veterinary use approved by the United States Food and
24Drug Administration.
25    (d) "Practice of pharmacy" means:
26        (1) the interpretation and the provision of assistance

 

 

SB2972- 16 -LRB101 19948 SPS 69555 b

1    in the monitoring, evaluation, and implementation of
2    prescription drug orders;
3        (2) the dispensing of prescription drug orders;
4        (3) participation in drug and device selection;
5        (4) drug administration limited to the administration
6    of oral, topical, injectable, and inhalation as follows:
7            (A) in the context of patient education on the
8        proper use or delivery of medications;
9            (B) vaccination of patients 14 years of age and
10        older pursuant to a valid prescription or standing
11        order, by a physician licensed to practice medicine in
12        all its branches, upon completion of appropriate
13        training, including how to address contraindications
14        and adverse reactions set forth by rule, with
15        notification to the patient's physician and
16        appropriate record retention, or pursuant to hospital
17        pharmacy and therapeutics committee policies and
18        procedures;
19            (B-5) following the initial administration of
20        long-acting or extended release form opioid
21        antagonists by a physician licensed to practice
22        medicine in all its branches, administration of
23        injections of long-acting or extended-release form
24        opioid antagonists for the treatment of substance use
25        disorder, pursuant to a valid prescription by a
26        physician licensed to practice medicine in all its

 

 

SB2972- 17 -LRB101 19948 SPS 69555 b

1        branches, upon completion of appropriate training,
2        including how to address contraindications and adverse
3        reactions, including, but not limited to, respiratory
4        depression and the performance of cardiopulmonary
5        resuscitation, set forth by rule, with notification to
6        the patient's physician and appropriate record
7        retention, or pursuant to hospital pharmacy and
8        therapeutics committee policies and procedures;
9            (C) administration of injections of
10        alpha-hydroxyprogesterone caproate, pursuant to a
11        valid prescription, by a physician licensed to
12        practice medicine in all its branches, upon completion
13        of appropriate training, including how to address
14        contraindications and adverse reactions set forth by
15        rule, with notification to the patient's physician and
16        appropriate record retention, or pursuant to hospital
17        pharmacy and therapeutics committee policies and
18        procedures; and
19            (D) administration of injections of long-term
20        antipsychotic medications pursuant to a valid
21        prescription by a physician licensed to practice
22        medicine in all its branches, upon completion of
23        appropriate training conducted by an Accreditation
24        Council of Pharmaceutical Education accredited
25        provider, including how to address contraindications
26        and adverse reactions set forth by rule, with

 

 

SB2972- 18 -LRB101 19948 SPS 69555 b

1        notification to the patient's physician and
2        appropriate record retention, or pursuant to hospital
3        pharmacy and therapeutics committee policies and
4        procedures.
5        (5) vaccination of patients ages 10 through 13 limited
6    to the Influenza (inactivated influenza vaccine and live
7    attenuated influenza intranasal vaccine) and Tdap (defined
8    as tetanus, diphtheria, acellular pertussis) vaccines,
9    pursuant to a valid prescription or standing order, by a
10    physician licensed to practice medicine in all its
11    branches, upon completion of appropriate training,
12    including how to address contraindications and adverse
13    reactions set forth by rule, with notification to the
14    patient's physician and appropriate record retention, or
15    pursuant to hospital pharmacy and therapeutics committee
16    policies and procedures;
17        (6) drug regimen review;
18        (7) drug or drug-related research;
19        (8) the provision of patient counseling;
20        (9) the practice of telepharmacy;
21        (10) the provision of those acts or services necessary
22    to provide pharmacist care;
23        (11) medication therapy management; and
24        (12) the responsibility for compounding and labeling
25    of drugs and devices (except labeling by a manufacturer,
26    repackager, or distributor of non-prescription drugs and

 

 

SB2972- 19 -LRB101 19948 SPS 69555 b

1    commercially packaged legend drugs and devices), proper
2    and safe storage of drugs and devices, and maintenance of
3    required records; and .
4        (13) the assessment and consultation of patients and
5    dispensing of hormonal contraceptives pursuant to the
6    standing order under Section 2310-705 of the Department of
7    Public Health Powers and Duties Law of the Civil
8    Administrative Code of Illinois.
9    A pharmacist who performs any of the acts defined as the
10practice of pharmacy in this State must be actively licensed as
11a pharmacist under this Act.
12    (e) "Prescription" means and includes any written, oral,
13facsimile, or electronically transmitted order for drugs or
14medical devices, issued by a physician licensed to practice
15medicine in all its branches, dentist, veterinarian, podiatric
16physician, or optometrist, within the limits of his or her
17license, by a physician assistant in accordance with subsection
18(f) of Section 4, or by an advanced practice registered nurse
19in accordance with subsection (g) of Section 4, containing the
20following: (1) name of the patient; (2) date when prescription
21was issued; (3) name and strength of drug or description of the
22medical device prescribed; and (4) quantity; (5) directions for
23use; (6) prescriber's name, address, and signature; and (7) DEA
24registration number where required, for controlled substances.
25The prescription may, but is not required to, list the illness,
26disease, or condition for which the drug or device is being

 

 

SB2972- 20 -LRB101 19948 SPS 69555 b

1prescribed. DEA registration numbers shall not be required on
2inpatient drug orders. A prescription for medication other than
3controlled substances shall be valid for up to 15 months from
4the date issued for the purpose of refills, unless the
5prescription states otherwise.
6    (f) "Person" means and includes a natural person,
7partnership, association, corporation, government entity, or
8any other legal entity.
9    (g) "Department" means the Department of Financial and
10Professional Regulation.
11    (h) "Board of Pharmacy" or "Board" means the State Board of
12Pharmacy of the Department of Financial and Professional
13Regulation.
14    (i) "Secretary" means the Secretary of Financial and
15Professional Regulation.
16    (j) "Drug product selection" means the interchange for a
17prescribed pharmaceutical product in accordance with Section
1825 of this Act and Section 3.14 of the Illinois Food, Drug and
19Cosmetic Act.
20    (k) "Inpatient drug order" means an order issued by an
21authorized prescriber for a resident or patient of a facility
22licensed under the Nursing Home Care Act, the ID/DD Community
23Care Act, the MC/DD Act, the Specialized Mental Health
24Rehabilitation Act of 2013, the Hospital Licensing Act, or the
25University of Illinois Hospital Act, or a facility which is
26operated by the Department of Human Services (as successor to

 

 

SB2972- 21 -LRB101 19948 SPS 69555 b

1the Department of Mental Health and Developmental
2Disabilities) or the Department of Corrections.
3    (k-5) "Pharmacist" means an individual health care
4professional and provider currently licensed by this State to
5engage in the practice of pharmacy.
6    (l) "Pharmacist in charge" means the licensed pharmacist
7whose name appears on a pharmacy license and who is responsible
8for all aspects of the operation related to the practice of
9pharmacy.
10    (m) "Dispense" or "dispensing" means the interpretation,
11evaluation, and implementation of a prescription drug order,
12including the preparation and delivery of a drug or device to a
13patient or patient's agent in a suitable container
14appropriately labeled for subsequent administration to or use
15by a patient in accordance with applicable State and federal
16laws and regulations. "Dispense" or "dispensing" does not mean
17the physical delivery to a patient or a patient's
18representative in a home or institution by a designee of a
19pharmacist or by common carrier. "Dispense" or "dispensing"
20also does not mean the physical delivery of a drug or medical
21device to a patient or patient's representative by a
22pharmacist's designee within a pharmacy or drugstore while the
23pharmacist is on duty and the pharmacy is open.
24    (n) "Nonresident pharmacy" means a pharmacy that is located
25in a state, commonwealth, or territory of the United States,
26other than Illinois, that delivers, dispenses, or distributes,

 

 

SB2972- 22 -LRB101 19948 SPS 69555 b

1through the United States Postal Service, commercially
2acceptable parcel delivery service, or other common carrier, to
3Illinois residents, any substance which requires a
4prescription.
5    (o) "Compounding" means the preparation and mixing of
6components, excluding flavorings, (1) as the result of a
7prescriber's prescription drug order or initiative based on the
8prescriber-patient-pharmacist relationship in the course of
9professional practice or (2) for the purpose of, or incident
10to, research, teaching, or chemical analysis and not for sale
11or dispensing. "Compounding" includes the preparation of drugs
12or devices in anticipation of receiving prescription drug
13orders based on routine, regularly observed dispensing
14patterns. Commercially available products may be compounded
15for dispensing to individual patients only if all of the
16following conditions are met: (i) the commercial product is not
17reasonably available from normal distribution channels in a
18timely manner to meet the patient's needs and (ii) the
19prescribing practitioner has requested that the drug be
20compounded.
21    (p) (Blank).
22    (q) (Blank).
23    (r) "Patient counseling" means the communication between a
24pharmacist or a student pharmacist under the supervision of a
25pharmacist and a patient or the patient's representative about
26the patient's medication or device for the purpose of

 

 

SB2972- 23 -LRB101 19948 SPS 69555 b

1optimizing proper use of prescription medications or devices.
2"Patient counseling" may include without limitation (1)
3obtaining a medication history; (2) acquiring a patient's
4allergies and health conditions; (3) facilitation of the
5patient's understanding of the intended use of the medication;
6(4) proper directions for use; (5) significant potential
7adverse events; (6) potential food-drug interactions; and (7)
8the need to be compliant with the medication therapy. A
9pharmacy technician may only participate in the following
10aspects of patient counseling under the supervision of a
11pharmacist: (1) obtaining medication history; (2) providing
12the offer for counseling by a pharmacist or student pharmacist;
13and (3) acquiring a patient's allergies and health conditions.
14    (s) "Patient profiles" or "patient drug therapy record"
15means the obtaining, recording, and maintenance of patient
16prescription information, including prescriptions for
17controlled substances, and personal information.
18    (t) (Blank).
19    (u) "Medical device" or "device" means an instrument,
20apparatus, implement, machine, contrivance, implant, in vitro
21reagent, or other similar or related article, including any
22component part or accessory, required under federal law to bear
23the label "Caution: Federal law requires dispensing by or on
24the order of a physician". A seller of goods and services who,
25only for the purpose of retail sales, compounds, sells, rents,
26or leases medical devices shall not, by reasons thereof, be

 

 

SB2972- 24 -LRB101 19948 SPS 69555 b

1required to be a licensed pharmacy.
2    (v) "Unique identifier" means an electronic signature,
3handwritten signature or initials, thumb print, or other
4acceptable biometric or electronic identification process as
5approved by the Department.
6    (w) "Current usual and customary retail price" means the
7price that a pharmacy charges to a non-third-party payor.
8    (x) "Automated pharmacy system" means a mechanical system
9located within the confines of the pharmacy or remote location
10that performs operations or activities, other than compounding
11or administration, relative to storage, packaging, dispensing,
12or distribution of medication, and which collects, controls,
13and maintains all transaction information.
14    (y) "Drug regimen review" means and includes the evaluation
15of prescription drug orders and patient records for (1) known
16allergies; (2) drug or potential therapy contraindications;
17(3) reasonable dose, duration of use, and route of
18administration, taking into consideration factors such as age,
19gender, and contraindications; (4) reasonable directions for
20use; (5) potential or actual adverse drug reactions; (6)
21drug-drug interactions; (7) drug-food interactions; (8)
22drug-disease contraindications; (9) therapeutic duplication;
23(10) patient laboratory values when authorized and available;
24(11) proper utilization (including over or under utilization)
25and optimum therapeutic outcomes; and (12) abuse and misuse.
26    (z) "Electronically transmitted prescription" means a

 

 

SB2972- 25 -LRB101 19948 SPS 69555 b

1prescription that is created, recorded, or stored by electronic
2means; issued and validated with an electronic signature; and
3transmitted by electronic means directly from the prescriber to
4a pharmacy. An electronic prescription is not an image of a
5physical prescription that is transferred by electronic means
6from computer to computer, facsimile to facsimile, or facsimile
7to computer.
8    (aa) "Medication therapy management services" means a
9distinct service or group of services offered by licensed
10pharmacists, physicians licensed to practice medicine in all
11its branches, advanced practice registered nurses authorized
12in a written agreement with a physician licensed to practice
13medicine in all its branches, or physician assistants
14authorized in guidelines by a supervising physician that
15optimize therapeutic outcomes for individual patients through
16improved medication use. In a retail or other non-hospital
17pharmacy, medication therapy management services shall consist
18of the evaluation of prescription drug orders and patient
19medication records to resolve conflicts with the following:
20        (1) known allergies;
21        (2) drug or potential therapy contraindications;
22        (3) reasonable dose, duration of use, and route of
23    administration, taking into consideration factors such as
24    age, gender, and contraindications;
25        (4) reasonable directions for use;
26        (5) potential or actual adverse drug reactions;

 

 

SB2972- 26 -LRB101 19948 SPS 69555 b

1        (6) drug-drug interactions;
2        (7) drug-food interactions;
3        (8) drug-disease contraindications;
4        (9) identification of therapeutic duplication;
5        (10) patient laboratory values when authorized and
6    available;
7        (11) proper utilization (including over or under
8    utilization) and optimum therapeutic outcomes; and
9        (12) drug abuse and misuse.
10    "Medication therapy management services" includes the
11following:
12        (1) documenting the services delivered and
13    communicating the information provided to patients'
14    prescribers within an appropriate time frame, not to exceed
15    48 hours;
16        (2) providing patient counseling designed to enhance a
17    patient's understanding and the appropriate use of his or
18    her medications; and
19        (3) providing information, support services, and
20    resources designed to enhance a patient's adherence with
21    his or her prescribed therapeutic regimens.
22    "Medication therapy management services" may also include
23patient care functions authorized by a physician licensed to
24practice medicine in all its branches for his or her identified
25patient or groups of patients under specified conditions or
26limitations in a standing order from the physician.

 

 

SB2972- 27 -LRB101 19948 SPS 69555 b

1    "Medication therapy management services" in a licensed
2hospital may also include the following:
3        (1) reviewing assessments of the patient's health
4    status; and
5        (2) following protocols of a hospital pharmacy and
6    therapeutics committee with respect to the fulfillment of
7    medication orders.
8    (bb) "Pharmacist care" means the provision by a pharmacist
9of medication therapy management services, with or without the
10dispensing of drugs or devices, intended to achieve outcomes
11that improve patient health, quality of life, and comfort and
12enhance patient safety.
13    (cc) "Protected health information" means individually
14identifiable health information that, except as otherwise
15provided, is:
16        (1) transmitted by electronic media;
17        (2) maintained in any medium set forth in the
18    definition of "electronic media" in the federal Health
19    Insurance Portability and Accountability Act; or
20        (3) transmitted or maintained in any other form or
21    medium.
22    "Protected health information" does not include
23individually identifiable health information found in:
24        (1) education records covered by the federal Family
25    Educational Right and Privacy Act; or
26        (2) employment records held by a licensee in its role

 

 

SB2972- 28 -LRB101 19948 SPS 69555 b

1    as an employer.
2    (dd) "Standing order" means a specific order for a patient
3or group of patients issued by a physician licensed to practice
4medicine in all its branches in Illinois.
5    (ee) "Address of record" means the designated address
6recorded by the Department in the applicant's application file
7or licensee's license file maintained by the Department's
8licensure maintenance unit.
9    (ff) "Home pharmacy" means the location of a pharmacy's
10primary operations.
11    (gg) "Email address of record" means the designated email
12address recorded by the Department in the applicant's
13application file or the licensee's license file, as maintained
14by the Department's licensure maintenance unit.
15(Source: P.A. 100-208, eff. 1-1-18; 100-497, eff. 9-8-17;
16100-513, eff. 1-1-18; 100-804, eff. 1-1-19; 100-863, eff.
178-14-18; 101-349, eff. 1-1-20.)
 
18    Section 40. The Illinois Public Aid Code is amended by
19adding Section 5-5.12d as follows:
 
20    (305 ILCS 5/5-5.12d new)
21    Sec. 5-5.12d. Coverage for patient care services for
22hormonal contraceptives provided by a pharmacist.
23    (a) Subject to approval by the federal Centers for Medicare
24and Medicaid Services, the medical assistance program,

 

 

SB2972- 29 -LRB101 19948 SPS 69555 b

1including both the fee-for-service and managed care medical
2assistance programs established under this Article, shall
3cover patient care services provided by a pharmacist for
4hormonal contraceptives assessment and consultation.
5    (b) The Department shall establish a fee schedule for
6patient care services provided by a pharmacist for hormonal
7contraceptives assessment and consultation.
8    (c) The rate of reimbursement for patient care services
9provided by a pharmacist for hormonal contraceptives
10assessment and consultation shall be at 85% of the fee schedule
11for physician services by the medical assistance program.
12    (d) A pharmacist must be enrolled in the medical assistance
13program as an ordering and referring provider prior to
14providing hormonal contraceptives assessment and consultation
15that is submitted by a pharmacy or pharmacist provider for
16reimbursement pursuant to this Section.
17    (e) The Director shall seek any necessary federal waivers
18or approvals to implement this Section. This Section shall not
19be implemented until the receipt of all necessary federal
20waivers or approvals or until January 1, 2022, whichever comes
21first. If federal approval is not obtained by January 1, 2022,
22the provisions of this Section shall be implemented using State
23funds.
24    (f) This Section does not restrict or prohibit any services
25currently provided by pharmacists as authorized by law,
26including, but not limited to, pharmacist services provided

 

 

SB2972- 30 -LRB101 19948 SPS 69555 b

1under this Code or authorized under the Illinois Title XIX
2State Plan.
3    (g) The Department shall adopt administrative rules for
4this Section as soon as practicable but no later than May 1,
52020.
 
6    Section 95. No acceleration or delay. Where this Act makes
7changes in a statute that is represented in this Act by text
8that is not yet or no longer in effect (for example, a Section
9represented by multiple versions), the use of that text does
10not accelerate or delay the taking effect of (i) the changes
11made by this Act or (ii) provisions derived from any other
12Public Act.
 
13    Section 99. Effective date. This Act takes effect January
141, 2021.

 

 

SB2972- 31 -LRB101 19948 SPS 69555 b

1 INDEX
2 Statutes amended in order of appearance
3    5 ILCS 375/6.11
4    20 ILCS 2310/2310-705 new
5    55 ILCS 5/5-1069.3
6    65 ILCS 5/10-4-2.3
7    105 ILCS 5/10-22.3f
8    215 ILCS 5/356z.43 new
9    225 ILCS 85/3
10    305 ILCS 5/5-5.12d new